01—Abstract
Summary
Summary of the 8-K filed August 28, 2026. Cited figures are marked; the original filing is the authoritative source.
Edwards Lifesciences Corporation (EW) has announced the upcoming retirement of Donald E.
Bobo, Jr., Corporate Vice President of Strategy and Corporate Development. Mr. Bobo intends to retire by mid-year 2027, with a transition of his duties expected to occur during 2027.
The company has initiated a search process to identify his successor. Following his retirement, Mr. Bobo is expected to continue contributing to the company as a consultant until the end of 2027, ensuring a smooth handover and continued strategic support.
02—Key points
Key Highlights
- Donald E. Bobo, Jr., Corporate Vice President, Strategy and Corporate Development, will retire by mid-year 2027.
- A search for Mr. Bobo's successor has commenced.
- The transition of duties is anticipated to take place during 2027.
- Mr. Bobo will serve as a consultant to the company through the end of 2027 post-retirement.
- This announcement pertains to a key executive role focused on strategy and corporate development.
03—Questions
Frequently Asked Questions
When will Donald E. Bobo, Jr. officially retire?
Mr. Bobo is expected to retire from his executive role by mid-year 2027.
Will Mr. Bobo's departure impact the company's strategy or development?
While a successor is being sought, Mr. Bobo will continue as a consultant through the end of 2027, which should help ensure continuity and support the transition of responsibilities.
What is the significance of the Corporate Vice President, Strategy and Corporate Development role?
This role is crucial for identifying and executing strategic initiatives, mergers, acquisitions, and other corporate development activities that drive the company's growth and competitive positioning.
Has a successor been identified yet?
No, the company has stated that a selection process will begin promptly to identify a successor.
04—Continue